Benchling Raises $14.5M From Benchmark to Advance Life Sciences Research Announces 500% ARR Growth and more than 100,000 scientists using its platform SAN FRANCISCO, June 14, 2018-- Today Benchling, the data management and collaboration platform built to advance life sciences research, announced it has closed $14.5M in Series B funding. The round was led by Benchmark, with participation from F-Prime Capital, a global venture capital firm associated with Fidelity Investments, and returning investor Thrive Capital. Benchmark General Partner Eric Vishria will be joining the board of directors.